Published in Radiology on January 25, 2008
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (2009) 7.44
Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford) (2013) 1.50
Recommendations for the management of tyrosinaemia type 1. Orphanet J Rare Dis (2013) 1.40
Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging. Eur Radiol (2010) 1.37
The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study. Eur Radiol (2010) 1.36
Role of diffusion-weighted magnetic resonance imaging in the differential diagnosis of focal hepatic lesions. World J Gastroenterol (2009) 1.18
Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma. Eur Radiol (2009) 1.16
Imaging diagnosis of pancreatic cancer: a state-of-the-art review. World J Gastroenterol (2014) 1.15
Diffusion weighted imaging in the liver. World J Gastroenterol (2010) 1.15
Apparent diffusion coefficient measurements in the differentiation between benign and malignant lesions: a systematic review. Insights Imaging (2012) 1.11
Recent Advances in CT and MR Imaging for Evaluation of Hepatocellular Carcinoma. Liver Cancer (2012) 1.02
Protocol requirements and diagnostic value of PET/MR imaging for liver metastasis detection. Eur J Nucl Med Mol Imaging (2013) 1.01
Characterization of focal liver lesions using quantitative techniques: comparison of apparent diffusion coefficient values and T2 relaxation times. Eur Radiol (2012) 0.98
Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases. Br J Radiol (2011) 0.97
Diffusion-weighted imaging for the detection of mesenteric small bowel tumours with Magnetic Resonance--enterography. Eur Radiol (2014) 0.96
Whole-body diffusion-weighted imaging for staging malignant lymphoma in children. Pediatr Radiol (2010) 0.96
Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI. Eur Radiol (2010) 0.96
Diffusion MRI of acute pancreatitis and comparison with normal individuals using ADC values. Emerg Radiol (2011) 0.95
The detection and discrimination of malignant and benign focal hepatic lesions: T2 weighted vs diffusion-weighted MRI. Br J Radiol (2010) 0.93
Early prediction of anticancer effects with diffusion-weighted MR imaging in patients with colorectal liver metastases following selective internal radiotherapy. Eur Radiol (2010) 0.93
Whole body MRI: improved lesion detection and characterization with diffusion weighted techniques. J Magn Reson Imaging (2013) 0.92
Diffusion weighted magnetic resonance imaging of the breast: protocol optimization, interpretation, and clinical applications. Magn Reson Imaging Clin N Am (2013) 0.91
Intravoxel incoherent motion model-based liver lesion characterisation from three b-value diffusion-weighted MRI. Eur Radiol (2013) 0.90
Advances in diffusion-weighted imaging. Radiol Clin North Am (2015) 0.89
Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging. Eur Radiol (2015) 0.88
Abdominal applications of diffusion-weighted magnetic resonance imaging: Where do we stand. World J Radiol (2013) 0.88
Diffusion-weighted imaging of the liver: usefulness of ADC values in the differential diagnosis of focal lesions and effect of ROI methods on ADC measurements. MAGMA (2012) 0.87
Diffusion-weighted imaging outside the brain: Consensus statement from an ISMRM-sponsored workshop. J Magn Reson Imaging (2016) 0.86
MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma. World J Gastroenterol (2009) 0.85
Role of Diffusion Weighted Imaging (DWI) for Hepatocellular Carcinoma (HCC) Detection and its Grading on 3T MRI: A Prospective Study. J Clin Exp Hepatol (2016) 0.85
Role of diffusion-weighted magnetic resonance imaging in the diagnosis of extrahepatic cholangiocarcinoma. World J Gastroenterol (2010) 0.85
Is DWI/ADC a useful tool in the characterization of focal hepatic lesions suspected of malignancy? PLoS One (2014) 0.85
Diffusion-weighted MR imaging in gynecologic cancers. J Gynecol Oncol (2011) 0.85
Diffusion-weighted imaging of biliopancreatic disorders: correlation with conventional magnetic resonance imaging. World J Gastroenterol (2012) 0.83
Diagnosis value of focal liver lesions with SonoVue®-enhanced ultrasound compared with contrast-enhanced computed tomography and contrast-enhanced MRI: a meta-analysis. J Cancer Res Clin Oncol (2011) 0.83
The effect of gadoxetic acid enhancement on lesion detection and characterisation using T₂ weighted imaging and diffusion weighted imaging of the liver. Br J Radiol (2010) 0.82
Small hypervascular hepatocellular carcinomas: value of diffusion-weighted imaging compared with "washout" appearance on dynamic MRI. Br J Radiol (2012) 0.82
Diffusion-weighted imaging of the liver: an update. Cancer Imaging (2013) 0.82
Added value of diffusion-weighted acquisitions in MRI of the abdomen and pelvis. AJR Am J Roentgenol (2014) 0.81
Diffusion-weighted MRI for uveal melanoma liver metastasis detection. Eur Radiol (2015) 0.81
Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancer. World J Radiol (2011) 0.80
Appearances of colorectal hepatic metastases at diffusion-weighted MRI compared with histopathology: initial observations. Br J Radiol (2011) 0.80
Diffusion-weighted imaging in pediatric body magnetic resonance imaging. Pediatr Radiol (2016) 0.80
Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour. Eur Radiol (2015) 0.79
Evaluation of Hepatic Tumors Using Intravoxel Incoherent Motion Diffusion-Weighted MRI. Med Sci Monit (2016) 0.79
Imaging of HCC-Current State of the Art. Diagnostics (Basel) (2015) 0.79
A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases. Eur Radiol (2016) 0.79
Comparison of Dynamic and Liver-Specific Gadoxetic Acid Contrast-Enhanced MRI versus Apparent Diffusion Coefficients. PLoS One (2013) 0.78
Grading of small hepatocellular carcinomas (≤2 cm): correlation between histology, T2 and diffusion-weighted imaging. Br J Radiol (2014) 0.78
Magnetic resonance imaging of the cirrhotic liver: An update. World J Hepatol (2015) 0.78
Non-invasive diagnostic imaging of colorectal liver metastases. World J Radiol (2015) 0.78
Functional imaging in lung cancer. Clin Physiol Funct Imaging (2013) 0.78
Diffusion-weighted MRI in a liver protocol: its role in focal lesion detection. World J Radiol (2012) 0.78
Diffusion-weighted and T2-weighted MR imaging for colorectal liver metastases detection in a rat model at 7 T: a comparative study using histological examination as reference. Eur Radiol (2013) 0.78
Impact of post-processing methods on apparent diffusion coefficient values. Eur Radiol (2016) 0.78
Focal nodular hyperplasia: characterisation at gadoxetic acid-enhanced MRI and diffusion-weighted MRI. Br J Radiol (2013) 0.77
The role of diffusion-weighted MR imaging for differentiating benign from malignant bile duct strictures. Eur Radiol (2014) 0.77
Comparison of magnetic resonance elastography and diffusion-weighted imaging for differentiating benign and malignant liver lesions. Eur Radiol (2015) 0.77
A maximum-likelihood method to estimate a single ADC value of lesions using diffusion MRI. Magn Reson Med (2016) 0.77
Impact of field strength and RF excitation on abdominal diffusion-weighted magnetic resonance imaging. World J Radiol (2013) 0.77
Magnetic resonance imaging: Review of imaging techniques and overview of liver imaging. World J Radiol (2010) 0.77
Diffusion-weighted MR imaging for the differentiation of malignant from benign strictures in the periampullary region. Eur Radiol (2012) 0.77
Utility of ADC measurement on diffusion-weighted MRI in differentiation of prostate cancer, normal prostate and prostatitis. Quant Imaging Med Surg (2013) 0.77
Comparison of diffusion-weighted imaging and T2-weighted single shot fast spin-echo: Implications for LI-RADS characterization of hepatocellular carcinoma. Magn Reson Imaging (2016) 0.76
Diffusion-weighted imaging of the liver: techniques and applications. Magn Reson Imaging Clin N Am (2014) 0.76
Utility of diffusion-weighted imaging to assess hepatocellular carcinoma viability following transarterial chemoembolization. Oncol Lett (2014) 0.76
Effect of imaging parameters on the accuracy of apparent diffusion coefficient and optimization strategies. Diagn Interv Radiol (2015) 0.76
Use of non-invasive imaging to monitor response to aflibercept treatment in murine models of colorectal cancer liver metastases. Clin Exp Metastasis (2016) 0.75
DWI/ADC in Differentiation of Benign from Malignant Focal Liver Lesion. Acta Inform Med (2016) 0.75
Imaging of hepatocellular carcinoma and image guided therapies - how we do it. Cancer Imaging (2017) 0.75
Denoising MR images using non-local means filter with combined patch and pixel similarity. PLoS One (2014) 0.75
Assessment of the Focal Hepatic Lesions Using Diffusion Tensor Magnetic Resonance Imaging. J Med Signals Sens (2016) 0.75
"Vanishing liver metastases"-A real challenge for liver surgeons. Hepatobiliary Surg Nutr (2014) 0.75
Correcting partial volume effects in biexponential T2 estimation of small lesions. Magn Reson Med (2014) 0.75
Apparent diffusion coefficient normalization of normal liver: Will it improve the reproducibility of diffusion-weighted imaging at different MR scanners as a new biomarker? Medicine (Baltimore) (2017) 0.75
Intra-Individual, Inter-Vendor Comparison of Diffusion-Weighted MR Imaging of Upper Abdominal Organs at 3.0 Tesla with an Emphasis on the Value of Normalization with the Spleen. Korean J Radiol (2016) 0.75
Gd-EOB-DTPA-enhanced and diffusion-weighted magnetic resonance findings in hepatic epithelioid angiomyolipoma: A case report. Oncol Lett (2015) 0.75
Diffusion-Weighted Imaging with Two Different b-Values in Detection of Solid Focal Liver Lesions. Biomed Res Int (2016) 0.75
Diffusion-weighted MR imaging of non-complicated hepatic cysts: Value of 3T computed diffusion-weighted imaging. Eur J Radiol Open (2016) 0.75
Morphological and functional MDCT: problem-solving tool and surrogate biomarker for hepatic disease clinical care and drug discovery in the era of personalized medicine. Hepat Med (2010) 0.75
Diffusion-weighted MR imaging before and after contrast enhancement with superparamagnetic iron oxide for assessment of hepatic metastasis. Yonsei Med J (2012) 0.75
Preoperative CT versus diffusion weighted magnetic resonance imaging of the liver in patients with rectal cancer; a prospective randomized trial. PeerJ (2016) 0.75
Diffusion-Weighted MRI of Malignant versus Benign Portal Vein Thrombosis. Korean J Radiol (2016) 0.75
Beyond Histologic Staging: Emerging Imaging Strategies in Colorectal Cancer with Special Focus on Magnetic Resonance Imaging. Clin Colon Rectal Surg (2016) 0.75
Value of diffusion-weighted MR imaging for the detection of nephritis. ScientificWorldJournal (2013) 0.75
MRI of paediatric liver tumours: How we review and report. Cancer Imaging (2016) 0.75
MR-arterioportography: a new technical approach for detection of liver lesions. World J Gastroenterol (2011) 0.75
Development of a diffusion-weighted MRI protocol for multicentre abdominal imaging and evaluation of the effects of fasting on measurement of apparent diffusion coefficients (ADCs) in healthy liver. Br J Radiol (2015) 0.75
Diffusion magnetic resonance imaging: A molecular imaging tool caught between hope, hype and the real world of "personalized oncology". World J Radiol (2017) 0.75
Hepatic adenomatosis in liver cirrhosis. Eur J Radiol Open (2017) 0.75
Diffusion weighted magnetic resonance imaging of liver: Principles, clinical applications and recent updates. World J Hepatol (2017) 0.75
Advanced imaging techniques in pediatric body MRI. Pediatr Radiol (2017) 0.75
Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article. Medicine (Baltimore) (2017) 0.75
Staging laparoscopy in patients with hepatocellular carcinoma: is it useful? Surg Endosc (2012) 0.75
Image quality and diagnostic performance of free-breathing diffusion-weighted imaging for hepatocellular carcinoma. World J Hepatol (2017) 0.75
Gadoxetate-enhanced versus diffusion-weighted MRI for fused Ga-68-DOTANOC PET/MRI in patients with neuroendocrine tumours of the upper abdomen. Eur Radiol (2013) 0.75
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (2009) 7.44
Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin Cancer Res (2009) 4.58
Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol (2003) 4.44
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys (2004) 4.29
Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. Clin Cancer Res (2005) 4.23
Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol (2004) 3.56
Ventricular diverticula on cardiac CT: more common than previously thought. AJR Am J Roentgenol (2007) 2.98
Age-related total gray matter and white matter changes in normal adult brain. Part I: volumetric MR imaging analysis. AJNR Am J Neuroradiol (2002) 2.94
Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology (2008) 2.83
Nonenhanced MR angiography. Radiology (2008) 2.77
Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. J Immunol (2008) 2.61
Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response. Radiology (2006) 2.22
Finite element analysis applied to 3-T MR imaging of proximal femur microarchitecture: lower bone strength in patients with fragility fractures compared with control subjects. Radiology (2014) 2.15
Diffusion-weighted MR imaging of the pancreas: current status and recommendations. Radiology (2015) 2.11
Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol (2007) 2.02
Brain atrophy in mild or moderate traumatic brain injury: a longitudinal quantitative analysis. AJNR Am J Neuroradiol (2002) 2.02
Promoter hypermethylation profile of kidney cancer. Clin Cancer Res (2004) 2.02
Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging (2010) 1.96
Perfusion imaging of the liver: current challenges and future goals. Radiology (2005) 1.95
Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology (2009) 1.94
Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. Radiology (2013) 1.86
Pediatric autoimmune neuropsychiatric disorders associated with streptococcus: comparison of diagnosis and treatment in the community and at a specialty clinic. Pediatrics (2008) 1.85
Evaluation of bowel distention and bowel wall appearance by using neutral oral contrast agent for multi-detector row CT. Radiology (2005) 1.78
Small pulmonary nodules: volume measurement at chest CT--phantom study. Radiology (2003) 1.73
Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology (2004) 1.72
Age-related non-Gaussian diffusion patterns in the prefrontal brain. J Magn Reson Imaging (2008) 1.72
Free-breathing radial 3D fat-suppressed T1-weighted gradient echo sequence: a viable alternative for contrast-enhanced liver imaging in patients unable to suspend respiration. Invest Radiol (2011) 1.72
Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging. J Magn Reson Imaging (2010) 1.70
New paradigm in dose-finding trials: patient-specific dosing and beyond phase I. Clin Cancer Res (2005) 1.70
Short-term DTI predictors of cognitive dysfunction in mild traumatic brain injury. Brain Inj (2008) 1.68
Kidney function: glomerular filtration rate measurement with MR renography in patients with cirrhosis. Radiology (2011) 1.66
Endovascular treatment of spontaneous dissections of the superior mesenteric artery. J Vasc Surg (2009) 1.65
Resection of hepatocellular carcinoma with macroscopic vascular invasion. Ann Surg Oncol (2013) 1.65
Bosniak category IIF designation and surgery for complex renal cysts. J Urol (2009) 1.63
Dual-energy CT in patients suspected of having renal masses: can virtual nonenhanced images replace true nonenhanced images? Radiology (2009) 1.63
Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS. Neurology (2012) 1.62
Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience. Radiology (2008) 1.62
Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Radiology (2004) 1.61
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) (2010) 1.59
Dirty-appearing white matter in multiple sclerosis: volumetric MR imaging and magnetization transfer ratio histogram analysis. AJNR Am J Neuroradiol (2003) 1.59
Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience. Eur J Radiol (2012) 1.58
Assessing global invasion of newly diagnosed glial tumors with whole-brain proton MR spectroscopy. AJNR Am J Neuroradiol (2005) 1.56
Thalamus and cognitive impairment in mild traumatic brain injury: a diffusional kurtosis imaging study. J Neurotrauma (2011) 1.56
Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects. J Clin Invest (2012) 1.55
Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Neurosurgery (2006) 1.54
Diffusion-weighted imaging of the liver: comparison of navigator triggered and breathhold acquisitions. J Magn Reson Imaging (2009) 1.50
Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford) (2013) 1.50
Flexible Bayesian methods for cancer phase I clinical trials. Dose escalation with overdose control. Stat Med (2005) 1.50
Added value of multiplanar reformation in the multidetector CT evaluation of the female pelvis: a pictorial review. Radiographics (2009) 1.49
Free-breathing contrast-enhanced multiphase MRI of the liver using a combination of compressed sensing, parallel imaging, and golden-angle radial sampling. Invest Radiol (2013) 1.49
MRI of female urethral and periurethral disorders. AJR Am J Roentgenol (2004) 1.47
Dual-source computed tomography angiography image quality in patients with fast heart rates. J Cardiovasc Comput Tomogr (2009) 1.45
Accelerated phase-contrast cine MRI using k-t SPARSE-SENSE. Magn Reson Med (2011) 1.45
Sex-specific normalized reference values of heart and great vessel dimensions in cardiac CT angiography. AJR Am J Roentgenol (2011) 1.43
Optimal k-space sampling for dynamic contrast-enhanced MRI with an application to MR renography. Magn Reson Med (2009) 1.42
Multi-detector row CT attenuation measurements: assessment of intra- and interscanner variability with an anthropomorphic body CT phantom. Radiology (2007) 1.40
Comprehensive preoperative evaluation and repair of inguinal hernias at the time of open radical retropubic prostatectomy decreases risk of developing post-prostatectomy hernia. BJU Int (2012) 1.39
Variability of renal apparent diffusion coefficients: limitations of the monoexponential model for diffusion quantification. Radiology (2010) 1.38
Comparison of biexponential and monoexponential model of diffusion weighted imaging in evaluation of renal lesions: preliminary experience. Invest Radiol (2011) 1.37
Characterizing brain oxygen metabolism in patients with multiple sclerosis with T2-relaxation-under-spin-tagging MRI. J Cereb Blood Flow Metab (2012) 1.36
Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience. Am J Med Genet C Semin Med Genet (2003) 1.36
Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI. AJR Am J Roentgenol (2013) 1.35
Diffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla. J Magn Reson Imaging (2011) 1.34
Cochlear implantation in prelingually deafened adolescents. Arch Pediatr Adolesc Med (2012) 1.34
Age-related total gray matter and white matter changes in normal adult brain. Part II: quantitative magnetization transfer ratio histogram analysis. AJNR Am J Neuroradiol (2002) 1.33
Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. Arch Neurol (2007) 1.32
Optimization of b-value sampling for diffusion-weighted imaging of the kidney. Magn Reson Med (2011) 1.32
Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancer. Clin Cancer Res (2012) 1.31
Invariant natural killer T cells regulate breast cancer response to radiation and CTLA-4 blockade. Clin Cancer Res (2009) 1.31
Cardiovascular applications of phase-contrast MRI. AJR Am J Roentgenol (2009) 1.30
Myocardial infarction: optimization of inversion times at delayed contrast-enhanced MR imaging. Radiology (2004) 1.27
Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. AJNR Am J Neuroradiol (2005) 1.27
3D nongadolinium-enhanced ECG-gated MRA of the distal lower extremities: preliminary clinical experience. J Magn Reson Imaging (2008) 1.27
Assessment of thalamic perfusion in patients with mild traumatic brain injury by true FISP arterial spin labelling MR imaging at 3T. Brain Inj (2009) 1.27
Performance of an automated segmentation algorithm for 3D MR renography. Magn Reson Med (2007) 1.26
Individualized patient dosing in phase I clinical trials: the role of escalation with overdose control in PNU-214936. J Clin Oncol (2004) 1.23
Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: relationship to anhedonia. Arch Gen Psychiatry (2011) 1.23
Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver. AJR Am J Roentgenol (2009) 1.23